Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Methods

Published on 18 Nov 2024

Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Kang-shuai Li
Yi Liu
Tie-zhong Zhang
Yun-fei Xu
Zong-li Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1435639

1,720 views

Original Research

Published on 18 Nov 2024

Maslinic acid induces autophagy and ferroptosis via transcriptomic and metabolomic reprogramming in prostate cancer cells

in Pharmacology of Anti-Cancer Drugs

Fen Hu
Yuxi Sun
Yunfeng Zhang
Jiaxin Chen
Yingzi Deng
Yifei Li
Ruobing Li
Juan Zhang
Yongping Liang
Yan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453447

1,936 views

Correction

Published on 14 Nov 2024

Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Hui-Wen Yang
Yan Lan
An Li
Han Wu
Zi-Wei Song
Ai-Ling Wan
Yue Wang
Shi-Bao Li
Shuai Ji
Zhong-Cheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447095

583 views

Original Research

Published on 13 Nov 2024

Integrated analysis of single-cell and bulk transcriptome reveals hypoxia-induced immunosuppressive microenvironment to predict immunotherapy response in high-grade serous ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Qingshan Chen
Yue Zhang
Chao Wang
Hui Ding
Liqun Chi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450751

1,903 views
1 citation

Review

Published on 13 Nov 2024

Natural products: promising therapeutics for targeting regulatory immune cells in the tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Peng Song
Fei Song
Tingting Shao
Pengjuan Wang
Rongkun Li
Zhe-Sheng Chen
Zhaofang Zhang
Guozhong Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481850

1,385 views

Original Research

Published on 13 Nov 2024

Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation

in Pharmacology of Anti-Cancer Drugs

Mengdie Ou
Zhicheng Deng
Yonghui Shi
Jianxiong He
Zicong Ye
Ming Guo
Guohua Cheng
Junyan Wu
Li Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1496664

1,443 views

Review

Published on 13 Nov 2024

Anti-breast cancer effects of dairy protein active peptides, dairy products, and dairy protein-based nanoparticles

in Pharmacology of Anti-Cancer Drugs

Deju Zhang
Ying Yuan
Juan Xiong
Qingdong Zeng
Yiming Gan
Kai Jiang
Ni Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486264

1,700 views

Original Research

Published on 13 Nov 2024

Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer

in Pharmacology of Anti-Cancer Drugs

Fengjie Lin
Hanxuan Yang
Zongwei Huang
Ying Li
Qin Ding
Yunbin Ye
Sufang Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464830

1,056 views
1 citation

Case Report

Published on 13 Nov 2024

Renal microangiopathy induced by lenvatinib in hepatocellular carcinoma: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Cheng Xue
Linlin Cui
Jiaxin Chen
Yang Liu
Yufei Deng
Wenyi Xu
Zhiguo Mao
Jun Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420377

963 views
1 citation

Original Research

Published on 12 Nov 2024

Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2/SLC7A11/GPX4 signaling pathway

in Pharmacology of Anti-Cancer Drugs

Quancheng Han
Jingle Shi
Yiding Yu
Huajing Yuan
Yonghong Guo
Xiujuan Liu
Yitao Xue
Yan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1497733

2,097 views
1 citation

Review

Published on 11 Nov 2024

EAF2: a tumor suppressor gene with multi-aspect functions

in Pharmacology of Anti-Cancer Drugs

Wen-Tong Ji
Chun-Guo Cui
Yao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440511

633 views

Original Research

Published on 11 Nov 2024

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles

in Pharmacology of Anti-Cancer Drugs

Yuxuan Liu
Fuxu Yang
Zhimin Li
Ting Wang
Yeteng Mu
Yuxin Fan
Han Xue
Xiuli Hu
Xingang Guan
Hongxia Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487940

804 views
2 citations

Original Research

Published on 08 Nov 2024

Prognostic characteristics and drug sensitivity analysis of hepatocellular carcinoma based on histone modification-related genes: a multi-omics integrated study revealing potential therapeutic targets and individualized treatment strategies

in Pharmacology of Anti-Cancer Drugs

Ping Sun
Zheng Ding
Juan Chen
Kezhen Ou
Dianjie Zhou
Rui Li
Tianxiang Gu
He Sun
Ying Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489469

1,094 views

Review

Published on 08 Nov 2024

Exploring exosomes: novel diagnostic and therapeutic frontiers in thyroid cancer

in Pharmacology of Anti-Cancer Drugs

Sicheng Zhang
Yan Yang
Dianri Wang
Xueting Yang
Yongcong Cai
Chunyan Shui
Ruoyi Yang
Wen Tian
Chao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431581

1,504 views

Original Research

Published on 07 Nov 2024

A real-world study of adverse drug reactions of two isocitrate dehydrogenase inhibitor based on the US FDA adverse event reporting system and VigiAccess databases

in Pharmacology of Anti-Cancer Drugs

Mengmeng Peng
Qian Guo
Zihan Dang
Baiquan Zhang
Manjuan Li
Zixuan Wang
Xuemian Lu
Jie Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489045

1,562 views
1 citation

Review

Published on 07 Nov 2024

Inspired by an ancient Chinese Medicine prescription: the modern significance and potential of Yiyi Fuzi Baijiang San in treating diseases

in Pharmacology of Anti-Cancer Drugs

Yuli Zhang
Lu Zhang
Ni Chai
ZhiQiang Wan
Hua Sui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465387

950 views